MGRX

Mangoceuticals, Inc. · NASDAQ

Sector Health Technology
Industry Pharmaceuticals: Major
Website mangorx.com
Employees(FY) 2
ISIN US56270V2051

Performance

+1.23%

-2.76%

-45.11%

-31.67%

-40.53%

YTD

-71.61%

Profile

Mangoceuticals, Inc. develops, markets, and sells various men's wellness products and services through a telemedicine platform in the United States. The company provides erectile dysfunction and hair growth products under the Mango and Mango GROW brand names. It sells its products through its online website at mangorx.com. The company was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. is a subsidiary of Cohen Enterprises, Inc.

Advanced Technical Analysis

Technical Analysis of MGRX 2024-11-20

The stock indicators reflect a mixed sentiment, with the Moving Average Score at 36 indicating a bearish outlook, while the Oscillators Score of 56 suggests a neutral stance, and the overall Technical Score of 46 reinforces a neutral sentiment. This combination implies that while there are some bearish signals, the market is not strongly negativ...

Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

Stock Analysis of MGRX

Stock Rank

Recent News & Updates

2024-10-30 20:00
Mangoceuticals, Inc. Regains Full Compliance with Nasdaq Minimum Bid Price Requirement(Globenewswire)
2024-10-21 20:00
MangoRx Announces Formation of Strategy and Alternatives Committee(Globenewswire)
2024-10-21 05:10
MangoRx Responds to and Refutes Recent Claims Made by Eli Lilly(Globenewswire)
2024-10-17 20:45
Mangoceuticals, Inc. Announces Participation at the Centurion One Capital 2nd Annual Bahamas Summit 2024(Newsfilecorp)
2024-10-12 05:20
Mangoceuticals announces 1-for-15 reverse stock split(Yahoo Finance)
2024-10-11 05:15
MANGOCEUTICALS, INC. ANNOUNCES 1-FOR 15 REVERSE STOCK SPLIT AS PART OF NASDAQ COMPLIANCE PLAN(Globenewswire)
2024-10-02 20:30
MangoRx Introduces Oral Tirzepatide GLP-1 Receptor Agonist for Advanced Weight Loss Solutions(Globenewswire)
2024-09-30 19:30
MangoRx Addresses $49.3 Billion Global GLP-1 Market With Launch of Oral Semaglutide for Advanced Weight Loss Treatment(Globenewswire)
2024-08-14 21:25
MangoRx Reports 1,685% Increase in Shareholders' Equity From December 31, 2023, to $13.8MM, and 56% Increase in Year-Over-Year Revenue for First Half of 2024(Globenewswire)
2024-08-13 04:00
MangoRx Receives Certificate of Grant in India for its Respiratory Illness and Preventive Care Technology Patent(Globenewswire)
2024-08-08 20:15
MangoRx Completes Migration to DEA-Approved Telemedicine Platform, Accelerating Timeline of Oral Dissolvable GLP-1 Weight Loss Treatments Featuring Semaglutide and Tirzepatide(Globenewswire)
2024-08-07 20:30
MangoRx Receives Request for Proposal (RFP) From ISFLST for New Male Enhancement Product Exclusive for the Asian Market(Accesswire)
2024-07-24 18:00
Emerging Telemedicine Leaders: Stocks Shaping Healthcare's Digital Future(Newsdirect)
2024-07-23 20:15
MangoRx Initiates Efficacy Studies on its Patented Respiratory Illness Prevention Technology(Globenewswire)
2024-07-18 04:05
Mangoceuticals CEO Jacob Cohen Featured on Benzinga All-Access(Globenewswire)
2024-07-15 20:20
MangoRx Secures DEA Approval for Proprietary HIPAA-Compliant Operating System via Surescripts(Globenewswire)
2024-07-12 01:30
MangoRx Appoints Dr. Douglas Christianson, N.D. as Director of the Medical Research and Product Innovation Department(Globenewswire)
2024-07-10 20:15
MangoRx Announces Strategic Partnership for Expansion into Asia Pacific and Key Emerging Markets(Globenewswire)
2024-06-05 20:30
MangoRx Receives Notice of Acceptance for Patent Application in Australia for Respiratory Illness and Preventive Care Technology(Globenewswire)
2024-06-04 04:00
MangoRx Receives Patent Notice of Allowance in Japan for Revolutionary Preventive Care Technology Acquired from Intramont Technologies(Globenewswire)
2024-06-03 20:00
MangoRx to Introduce MOJO Pharmaceutical Compounded Formula Featuring Enclomiphene Citrate and Pregnenolone for Treatment of Low Testosterone and Male Hormone Imbalances(Globenewswire)
2024-05-27 20:30
Mangoceuticals, Inc. Announces Completion of First Batch of Mango ED Products for Marketing and Distribution in Mexico and Latin American Markets(Globenewswire)
2024-05-27 19:27
Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday(Investorplace)
2024-05-22 21:45
MangoRx Engages Renown International Digital and Performance Marketing Company Crakmedia to Champion its Digital Marketing Efforts(Accesswire)
2024-05-21 19:23
Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday(Investorplace)
2024-05-21 04:00
Why Is Mangoceuticals (MGRX) Stock Up 130% Today?(Investorplace)
2024-05-20 20:30
MangoRx to Introduce Oral Semaglutide and Tirzepatide in Response to Increasing Patient Demand for GLP-1 Medications(Globenewswire)
2024-05-16 09:53
MGRX Stock Earnings: Mangoceuticals Reported Results for Q1 2024(Investorplace)
2024-05-16 04:40
MangoRx Reports Revenue Growth of 108% in Q1 2024 Fueled by Amplified Customer Acquisition and Early Market Penetration(Globenewswire)
2024-05-01 20:00
Mangoceuticals Granted 180-Day Extension to Meet Nasdaq Minimum Bid Price Requirement and Conditional Approval of Compliance with Nasdaq's Minimum Stockholders' Equity Requirement(Globenewswire)

Page 1 of 3

previousnext

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.